LAB Projected Dividend Yield
Standard BioTools Inc ( NASDAQ : LAB )Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. Co.'s segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. Co. provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. 21 YEAR PERFORMANCE RESULTS |
LAB Dividend History Detail LAB Dividend News LAB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |